Previous 10 | Next 10 |
While the end of the pandemic and possible slowing of the economy may bring inflation down somewhat, we cannot avoid the ramifications tied to years of quantitative easing, rapid money supply growth, and unprecedented fiscal expansion. Virtually every time inflation spiked over the pa...
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion, Contender, An...
The war has already had impacts on commodities, intermediate products, and the supply chain. Inflation, which started rising rapidly twelve months ago, remains at a 40-year high. If higher interest rates and inflation characterize the landscape for the next several years, it likel...
--News Direct-- This spring, GBM is expanding its reach as they team up with the Quest Diagnostics Foundation, as part of the Quest for Health Equity (Q4HE) initiative, expanding the esteemed Green Bronx Machine Classroom Curriculum to 30 more schools in New York, Colorado, and Ohio...
--News Direct-- The American College of Healthcare Executives has named John W. Bluford III, LFACHE, as recipient of the 2022 President’s Award. Given by the president and CEO, the President’s Award is presented to individuals who have made outstanding contributions to the...
Quest Diagnostics is a company I covered a few months back, calling it overvalued and directing people who owned the stock to selling covered calls. I currently have a "HOLD" on DGX - I'm not changing it per this article. Let's see what the company can bring in 2022-2025, and why ...
--News Direct-- Quest Diagnostics, as part of the Quest for Health Equity (Q4HE) initiative, recently provided a $97,350 grant to Marlborough High School in Massachusetts to support Scholastic Aptitude Test (SAT) prep and Advanced Placement (AP) courses as well as the cost of the ex...
Quest Diagnostics (DGX -1.6%) was downgraded by Citi to Neutral from Buy with a price target of $140, down from $175, on post-COVID uncertainty. Citi analyst Patrick Donnelly said he has concerns around the company's margin outlook in 2022 and 2023 on the heels of higher internal investm...
Quest Diagnostics (NYSE:DGX) is extending its collaborating with IRIS (Intelligent Retinal Imaging Systems) to deliver diabetic retinal imaging services through its designated centers in the U.S. for diabetic retinopathy, a diabetes complication that can lead to blindness. The ...
Quest Diagnostics Adds Diabetic Retinopathy Screening Through its Patient Service Centers in Collaboration with IRIS PR Newswire New Capability Enables Individuals Identified as High-Risk by Participating Health Plans to Access Screening through a Quest Diagnostics Sit...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year PR Newswire Quest achieves top score of 100 on 2024 Disability Equality Index® Best Places to Work for Disability Inclusion SECAUCUS, N.J. , Aug. 1, 20...
NORTHAMPTON, MA / ACCESSWIRE / July 30, 2024 / Bread of Life Academy, a program under nonprofit Bread of Life Inc. -a Quest for Health Equity (Q4HE) grantee-recently held a graduation ceremony to celebrate a graduating class of 40 students pursuing careers as phlebotomists and community health ...
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer PR Newswire BALTIMORE, Md. and MONTREAL , July 29, 2024 /PRN...